1. Home
  2. PRTC vs VPG Comparison

PRTC vs VPG Comparison

Compare PRTC & VPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTC
  • VPG
  • Stock Information
  • Founded
  • PRTC 2015
  • VPG 2009
  • Country
  • PRTC United States
  • VPG United States
  • Employees
  • PRTC N/A
  • VPG N/A
  • Industry
  • PRTC Biotechnology: Pharmaceutical Preparations
  • VPG Electrical Products
  • Sector
  • PRTC Health Care
  • VPG Technology
  • Exchange
  • PRTC Nasdaq
  • VPG Nasdaq
  • Market Cap
  • PRTC 413.5M
  • VPG 374.5M
  • IPO Year
  • PRTC N/A
  • VPG N/A
  • Fundamental
  • Price
  • PRTC $16.75
  • VPG $29.77
  • Analyst Decision
  • PRTC Buy
  • VPG
  • Analyst Count
  • PRTC 1
  • VPG 0
  • Target Price
  • PRTC $45.00
  • VPG N/A
  • AVG Volume (30 Days)
  • PRTC 5.6K
  • VPG 88.8K
  • Earning Date
  • PRTC 08-28-2025
  • VPG 11-04-2025
  • Dividend Yield
  • PRTC N/A
  • VPG N/A
  • EPS Growth
  • PRTC N/A
  • VPG N/A
  • EPS
  • PRTC 0.20
  • VPG N/A
  • Revenue
  • PRTC $6,391,000.00
  • VPG $295,282,000.00
  • Revenue This Year
  • PRTC N/A
  • VPG N/A
  • Revenue Next Year
  • PRTC N/A
  • VPG $5.48
  • P/E Ratio
  • PRTC $7.61
  • VPG N/A
  • Revenue Growth
  • PRTC 1265.60
  • VPG N/A
  • 52 Week Low
  • PRTC $13.30
  • VPG $18.57
  • 52 Week High
  • PRTC $24.99
  • VPG $30.13
  • Technical
  • Relative Strength Index (RSI)
  • PRTC 43.45
  • VPG 61.71
  • Support Level
  • PRTC $15.78
  • VPG $27.54
  • Resistance Level
  • PRTC $16.50
  • VPG $29.81
  • Average True Range (ATR)
  • PRTC 0.57
  • VPG 0.88
  • MACD
  • PRTC -0.18
  • VPG 0.18
  • Stochastic Oscillator
  • PRTC 25.17
  • VPG 90.45

About PRTC PureTech Health plc

PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.

About VPG Vishay Precision Group Inc.

Vishay Precision Group Inc manufactures and markets sensors, and sensor-based measurement systems, as well as specialty resistors and strain gages based on proprietary technology. The company provides precision products and solutions, many of which are designed-in by customers, specializing in the growing markets of stress, force, weight, pressure, and current measurements. The company reports in three product segments: Sensors segment, Weighing Solutions segment, and Measurement Systems segment. It has a business presence in the United States and other countries. It generates the maximum of its revenue from the United States.

Share on Social Networks: